The Podocyte in Diabetic Kidney Disease
Approaching epidemic levels, diabetic kidney disease (DKD) is now the leading cause of end-stage renal disease (ESRD). Microalbuminuria is an early clinical marker of DKD that results from damage to the glomerular filtration barrier at the level of the highly differentiated glomerular podocyte cells...
Saved in:
Main Authors: | Erin Stitt-Cavanagh, Laura MacLoed, Chris R.J. Kennedy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2009.133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease
by: Zhaochen Guo, et al.
Published: (2025-02-01) -
Targeting endoplasmic reticulum stress: an innovative therapeutic strategy for podocyte-related kidney diseases
by: Jiao Lv, et al.
Published: (2025-01-01) -
Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement
by: Qian Wang, et al.
Published: (2020-01-01) -
Protective effect of compound K against podocyte injury in chronic kidney disease by maintaining mitochondrial homeostasis
by: Fugang Huang, et al.
Published: (2025-01-01) -
Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
by: Lili Zhang, et al.
Published: (2020-01-01)